• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按服务类型划分的戒烟热线结果。

Tobacco quitline outcomes by service type.

作者信息

Kerkvliet Jennifer L, Fahrenwald Nancy L

机构信息

South Dakota State University, USA.

College of Nursing South Dakota State University, USA.

出版信息

S D Med. 2014 Jan;67(1):25-9.

PMID:24601063
Abstract

BACKGROUND

Tobacco use is a burden in terms of mortality, chronic disease, and economic impact. Effective treatments exist to aid tobacco users who are motivated to quit. The South Dakota QuitLine provides coaching to all participants and the option of a cessation product (nicotine replacement therapy [NRT], or the prescription medications, varenicline or bupropion) at no cost. This study describes the types of services requested by South Dakota QuitLine participants and the associated cessation outcomes across service types.

METHODS

Data from South Dakota QuitLine enrollees during a four year period (2008 to 2011) were included. Enrollment data (demographics and tobacco use) and outcome evaluation data (30 day point prevalence - abstinence) collected seven months later were accessed (N = 11,603/26,876 enrollees, 43.2 percent response). The frequency of requests for each type of cessation service and associated cessation outcomes are reported. Abstinence at seven months was compared for the different services.

RESULTS

Frequencies of cessation services requested were coaching/varenicline (64.6 percent), coaching/bupropion (5 percent), coaching/NRT (22.6 percent), and coaching only (5.4 percent). Overall abstinence at seven months was 47.2 percent. Abstinence rates for service types were the following: coaching/varenicline (49.8 percent), coaching/bupropion (47.3 percent), coaching/NRT (42.9 percent), and coaching only (40.3 percent). Chi-square analysis and confidence interval comparisons identified significantly higher abstinence (p < .05) for varenicline/coaching in comparison to coaching only or coaching/NRT.

CONCLUSIONS

All service options available from the South Dakota QuitLine result in cessation rates of 40 percent or greater. Providers should assess tobacco use, advise users to quit, and refer to the South Dakota QuitLine.

摘要

背景

就死亡率、慢性病和经济影响而言,吸烟是一项负担。现有有效的治疗方法来帮助有戒烟意愿的吸烟者。南达科他州戒烟热线为所有参与者提供指导,并免费提供戒烟产品(尼古丁替代疗法 [NRT],或处方药伐尼克兰或安非他酮)。本研究描述了南达科他州戒烟热线参与者所要求的服务类型以及不同服务类型对应的戒烟结果。

方法

纳入了南达科他州戒烟热线在四年期间(2008年至2011年)的登记数据。获取了登记数据(人口统计学和吸烟情况)以及七个月后收集的结果评估数据(30天时间点流行率 - 戒烟情况)(N = 11,603/26,876名登记者,回复率43.2%)。报告了每种戒烟服务请求的频率以及相关的戒烟结果。比较了不同服务在七个月时的戒烟情况。

结果

所请求的戒烟服务频率分别为指导/伐尼克兰(64.6%)、指导/安非他酮(5%)、指导/NRT(22.6%)和仅指导(5.4%)。七个月时的总体戒烟率为47.2%。各服务类型的戒烟率如下:指导/伐尼克兰(49.8%)、指导/安非他酮(47.3%)、指导/NRT(42.9%)和仅指导(40.3%)。卡方分析和置信区间比较发现,与仅指导或指导/NRT相比,伐尼克兰/指导的戒烟率显著更高(p < .05)。

结论

南达科他州戒烟热线提供的所有服务选项的戒烟率均达到40%或更高。医疗服务提供者应评估吸烟情况,建议吸烟者戒烟,并转介至南达科他州戒烟热线。

相似文献

1
Tobacco quitline outcomes by service type.按服务类型划分的戒烟热线结果。
S D Med. 2014 Jan;67(1):25-9.
2
Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.使用伐尼克兰或尼古丁替代疗法的戒烟热线参与者的特征和戒断结果。
Nicotine Tob Res. 2010 Jun;12(6):567-73. doi: 10.1093/ntr/ntq045. Epub 2010 Apr 8.
3
Tobacco quitline outcomes for priority populations.重点人群的戒烟热线服务成果。
S D Med. 2015;Spec No:63-8.
4
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.希腊伐伦克林与安非他酮、尼古丁替代疗法和非药物戒烟的成本效益比较。
Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.
5
Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.伐尼克兰与安非他酮、尼古丁替代疗法及尼加拉瓜无辅助戒烟的成本分析。
Hosp Pract (1995). 2012 Feb;40(1):35-43. doi: 10.3810/hp.2012.02.946.
6
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.伐尼克兰在烟草依赖常规治疗中的应用:与尼古丁替代疗法的前后对比及对精神疾病患者的评估
Addiction. 2008 Jan;103(1):146-54. doi: 10.1111/j.1360-0443.2007.02083.x. Epub 2007 Nov 19.
7
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.使用伐尼克兰(一种选择性α4β2烟碱受体部分激动剂)戒烟:一项为期7周、随机、安慰剂和安非他酮对照试验以及1年随访的结果
Arch Intern Med. 2006;166(15):1561-8. doi: 10.1001/archinte.166.15.1561.
8
Varenicline in the management of smoking cessation: a single technology appraisal.伐尼克兰在戒烟管理中的应用:一项单技术评估。
Health Technol Assess. 2009 Sep;13 Suppl 2:9-13. doi: 10.3310/hta13suppl2/02.
9
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.使用BENESCO模型对中美洲和加勒比地区伐尼克兰与现有戒烟策略进行成本效益分析。
Hosp Pract (1995). 2012 Feb;40(1):24-34. doi: 10.3810/hp.2012.02.945.
10
Real-life effectiveness of smoking-cessation treatments in general practice clinics in Denmark. The Escape Smoke project.丹麦普通诊所戒烟治疗的实际效果。“逃离烟雾”项目。
Respir Med. 2015 Feb;109(2):218-27. doi: 10.1016/j.rmed.2014.12.007. Epub 2015 Jan 2.